Immatics NV
NASDAQ:IMTX
Immatics NV
Selling, General & Administrative
Immatics NV
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Immatics NV
NASDAQ:IMTX
|
Selling, General & Administrative
-€37.2m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-39%
|
CAGR 10-Years
N/A
|
|
BioNTech SE
NASDAQ:BNTX
|
Selling, General & Administrative
-€551.7m
|
CAGR 3-Years
-75%
|
CAGR 5-Years
-83%
|
CAGR 10-Years
N/A
|
|
MorphoSys AG
XETRA:MOR
|
Selling, General & Administrative
-€323.4m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-60%
|
CAGR 10-Years
-33%
|
|
CureVac NV
NASDAQ:CVAC
|
Selling, General & Administrative
-€81.8m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Biotest AG
XETRA:BIO
|
Selling, General & Administrative
-€104.2m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-1%
|
|
Formycon AG
XETRA:FYB
|
Selling, General & Administrative
-€14.1m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
N/A
|
See Also
What is Immatics NV's Selling, General & Administrative?
Selling, General & Administrative
-37.2m
EUR
Based on the financial report for Dec 31, 2023, Immatics NV's Selling, General & Administrative amounts to -37.2m EUR.
What is Immatics NV's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 5Y
-39%
Over the last year, the Selling, General & Administrative growth was -7%. The average annual Selling, General & Administrative growth rates for Immatics NV have been -4% over the past three years , -39% over the past five years .